Optimal therapy scheduling based on a pair of collaterally sensitive drugs
From MaRDI portal
Publication:1670458
DOI10.1101/196824zbMATH Open1396.92040OpenAlexW2764019985WikidataQ53686338 ScholiaQ53686338MaRDI QIDQ1670458FDOQ1670458
Authors: Nara Yoon, Robert Vander Velde, Andriy Marusyk, Jacob G. Scott 
Publication date: 5 September 2018
Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1101/196824
Recommendations
- Theoretical modeling of collaterally sensitive drug cycles: shaping heterogeneity to allow adaptive therapy
- scientific article; zbMATH DE number 1114142
- The application of mathematical modelling to aspects of adjuvant chemotherapy scheduling
- The worst drug rule revisited: mathematical modeling of cyclic cancer treatments
- scientific article; zbMATH DE number 819191
Medical applications (general) (92C50) Applications of optimal control and differential games (49N90)
Cites Work
- The mathematical modelling of adjuvant chemotherapy scheduling: incorporating the effects of protocol rest phases and pharmacokinetics
- The influence of toxicity constraints in models of chemotherapeutic protocol escalation
- A model for the resistance of tumor cells to cancer chemotherapeutic agents
- A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy
- An elementary approach to modeling drug resistance in cancer
- A single-cell approach in modeling the dynamics of tumor microregions
- The worst drug rule revisited: mathematical modeling of cyclic cancer treatments
- The application of mathematical modelling to aspects of adjuvant chemotherapy scheduling
- Optimal policies of non-cross-resistant chemotherapy on Goldie and Coldman's cancer model
Cited In (6)
- The impact of competition between cancer cells and healthy cells on optimal drug delivery
- Scheduling collateral sensitivity‐based cycling therapies toward eradication of drug‐resistant infections
- Theoretical modeling of collaterally sensitive drug cycles: shaping heterogeneity to allow adaptive therapy
- Modelling bistable tumour population dynamics to design effective treatment strategies
- The worst drug rule revisited: mathematical modeling of cyclic cancer treatments
- Inferring density-dependent population dynamics mechanisms through rate disambiguation for logistic birth-death processes
This page was built for publication: Optimal therapy scheduling based on a pair of collaterally sensitive drugs
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1670458)
